|
|
|
Abstract 【Objective】To explore the factors that influenced the onset of diabetic nephropathy (DN) in patients with type 1 diabetes. 【Methods】A total of 142 patients admitted to our hospital with type 1 diabetes were selected. According to whether there is DN, patients were divided into DN group and non-DN group. The clinical data of patients were collected, including gender, age, duration of diabetes, blood uric acid. Taking DN as an independent variable and other related indicators as the dependent variable, logistic single factor and multivariate regression analysis were used to explore the factors influencing the pathogenesis of DN in patients with type 1 diabetes 【Results】In the DN group, the duration of diabetes, HbA1C, diastolic blood pressure, blood uric acid and Hb were(8.31±2.28)years,(10.21±3.41)%,(81.59±12.72)mmHg、(306.38±129.02)μmol/L and(116.82±20.31)g/L, respectively, which were significantly higher than those in the non-DN group, i.e.(4.06±1.96)years,(9.41±2.51)%,(75.24±9.61)mmHg,(258.49±92.17)μmol/L and(131.41±14.41)g/L,respectively. The differences between the two groups were statistically significant (P<0.05). Univariate logistic regression analysis showed that the duration of diabetes ≥ 5 years, HbA1C, serum uric acid, diastolic blood pressure, Hb were associated with the onset of DN (P<0.05). Multivariate logistic regression analysis showed that the duration of diabetes ≥5 years, HbA1C, diastolic blood pressure, blood uric acid and Hb were independent risk factors for DN (P<0.05). 【Conclusion】 Diabetes duration ≥ 5 years, HbA1C, diastolic blood pressure, blood uric acid and Hb are independent risk factors for the onset of DN, therefore patients with type 1 diabetes should actively control blood pressure, blood sugar, and uric acid levels.
|
|
Received: 28 October 2018
|
|
|
|
|
|
[1] Tachibana H,Ogawa D,Sogawa N,et al.Metallothionein deficiency exacerbates diabetic nephropathy in streptozotocin-induced diabetic mice[J].Am J Physiol,2014,306(1 Pt.2):F105-F115.
[2] 万倩,张倩,薛耀明,等.2型糖尿病肾病患者白蛋白尿的危险因素分析[J].实用医学杂志,2015,43(8):1234-1237.
[3] 田勍,洪天配.美国糖尿病学会2017年版糖尿病医学诊疗标准的解读[J].中国糖尿病杂志,2017,25(7):577-581.
[4] 郭思若,张爱华.糖尿病肾病的诊断及鉴别诊断[J].中华全科医师杂志,2017,19(10):750-752.
[5] 陈关芬,辛丽芹.糖尿病肾病与合并糖尿病的非糖尿病肾病患者临床特征及预后比较[J].山东医药,2016,56(46):59-61.
[6] 吕元军,李长平.IL-17与糖尿病及糖尿病肾病关系的研究进展[J].天津医药,2017,45(7):781-784.
[7] 郭凯锋,陈海冰,贾伟平,等.糖尿病肾脏疾病的流行病学进展[J].医学研究杂志,2015,44(3):162-166.
[8] 郭笑丹,徐杰,田黎,等.2型糖尿病患者糖尿病肾病的危险因素临床分析[J].陕西医学杂志,2015,43(4):457-458.
[9] Ye H,Bai X,Gao H,et al.Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy[J].J Diabetes Complications,2014,28(1):96-100.
[10] Meng N,Zhang Y,Li H,et al.Association of Tumor Necrosis Factor Alpha Promoter Polymorphism (TNF-α 238G/A and TNF-α 308G/A) with Diabetic Mellitus, Diabetic Retinopathy and Diabetic Nephropathy: A Meta-analysis[J].Curr Eye Res,2014,39(2):194-203. |
| [1] |
. [J]. JOURNAL OF CLINICAL RESEARCH, 2019, 36(9): 1789-1790. |
|
|
|
2019, Vol. 36 
